Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein A1 pseudogene 45 (HNRNPA1P45) is a pseudogene—a non-functional copy derived from the HNRNPA1 gene—that does not encode a functional protein. Pseudogenes such as HNRNPA1P45 generally lack therapeutic relevance because they are not expressed as active proteins and lack enzyme, receptor, or transporter functions. While some pseudogenes can have regulatory roles (for example, acting as competitive endogenous RNAs), the specific function or involvement of HNRNPA1P45 in any biological process or pathology has not been established in the available literature. Therefore, it is not a drug target, biomarker, or disease gene in its own right, nor is it linked to any specific safety or therapeutic concerns. Note: You may be seeking information on HNRNPA1 (the functional gene) or another active heterogeneous nuclear ribonucleoprotein, which are well-characterized RNA-binding proteins implicated in RNA processing, telomere function, and multiple diseases; HNRNPA1P45 does not share these functional attributes and is instead categorized as a non-coding, non-functional pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 45 (HNRNPA1P45).